Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III. - Lu, Mengnan; Wang, Xueying; Sun, Na; Huang, Shaoping; Yang, Lin; Li, Dan (CNS Neuroscience & Therapeutics, 2024)